Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 1/2 1

Status

Unknown 2Completed 2

Sponsor Class

OTHER 416INDUSTRY 112NETWORK 53NIH 38OTHER_GOV 8UNKNOWN 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 7Head & Neck 4Thoracic 2Other neoplasm 1Breast 1

Conditions

Nasopharyngeal Carcinoma 3Nasopharyngeal Neoplasms 1

Interventions

Cisplatin 4sintilimab 2pembrolizumab 2anlotinib 2Aprepitant 2nimotuzumab 1nabiximols 1camrelizumab 1apatinib 1Radiotherapy, Intensity-Modulated 1Platinum Compounds 1Palonosetron 1Paclitaxel 1Ondansetron 1Olanzapine 1Gemcitabine 1Drug Therapy 1Dexamethasone 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
UNKNOWN × Cisplatin × Head & Neck × Clear all
NCT01817023 2021-01-29

The Role of Concurrent Chemotherapy for Lower Risk Locally Advanced Nasopharyngeal Carcinoma(NPC) in the Era of IMRT

ChineseAMS

Phase 3 Unknown
590 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT01187238 2020-07-16

The Value of Concurrent Chemoradiotherapy for Stage II Nasopharyngeal Carcinoma

ChineseAMS

Phase 2 Completed
84 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT03639467 2018-09-18

Study of Anlotinib Combined With Gemcitabine/Cisplatin in Advanced Nasopharyngeal Carcinoma

ChineseAMS

Phase 1/2 Unknown
40 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT01797900 2014-09-10

The Role of Induction Chemotherapy for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRT

ChineseAMS

Phase 2 Completed
130 enrolled
Head & Neck

Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡